Results 171 to 180 of about 953,056 (326)

PMC37 PATIENT REPORTED OUTCOME RECALL PERIODS IN LIGHT OF THE FINAL FDA GUIDANCE

, 2010
DMG Wild, Audra H. Nixon
openalex   +1 more source

The AJH Visits FDA [PDF]

, 2012
Michael H. Alderman
openalex   +1 more source

Real‐Time 3D Ultrasound Imaging with an Ultra‐Sparse, Low Power Architecture

Advanced Healthcare Materials, EarlyView.
This article presents a novel, ultra‐sparse ultrasound architecture that paves the way for wearable real‐time 3D imaging. By integrating a unique convolutional array with chirped data acquisition, the system achieves high‐resolution volumetric scans at a fraction of the power and hardware complexity.
Colin Marcus, Md Osman Goni Nayeem, Aastha Shah, Jason Hou, Shrihari Viswanath, Maya Eusebio, David Sadat, Anantha P. Chandrakasan, Tolga Ozmen, Canan Dagdeviren   +9 more
wiley   +1 more source

Supreme Court Amicus Brief Regarding Wyeth v. Diana Levine [PDF]

Prominent in arguments opposing preemption of state tort law liability for alleged inadequacies in prescription drug labeling is the argument that such liability can complement FDA regulation by improving on a regulatory scheme that fails to provide ...
Berndt, Ernst R., Calfee, John E., Hahn, Robert W., Philipson, Tomas J., Rubin, Paul H., Viscusi, W. Kip   +5 more
core   +1 more source

A Tri‐Culture Heart‐on‐a‐Chip Platform With iPSC‐Derived Cardiac Cells for Predictive Cardiotoxicity Testing

Advanced Healthcare Materials, EarlyView.
This study presents the first entirely isogenic heart‐on‐chip, unifying cardiomyocytes, fibroblasts, and endothelial cells from a single iPSC source. The platform reveals a critical biological insight: the endothelium actively shields cardiac tissue from drug‐induced toxicity, challenging the predictive accuracy of conventional, avascular models for ...
Karine Tadevosyan, Jose Yeste, Mar Alvarez, Denise Marrero, Laura Casado‐Medina, Yvonne Richaud‐Patin, Olalla García‐Iglesias, Jagoda Litowczenko, Alba Morillas Garcia, Anton Guimerà, Xavi Illa, Rosa Villa, Angel Raya   +12 more
wiley   +1 more source

Use and regulation of patient-specific three-dimensional printing in medicine: a survey of physician end-users. [PDF]

3D Print Med
Shaylor R, Lior Y, Shapiro J, Ferretto T, Rybicki FJ, Coles-Black J.   +5 more
europepmc   +1 more source

New FDA Breakthrough-Drug Category — Implications for Patients [PDF]

, 2014
Jonathan J. Darrow, Jerry Avorn, Aaron S. Kesselheim   +2 more
openalex   +1 more source

Molecular Design of Highly Efficient Heavy‐Atom‐Free Near‐Infrared Cyanine Photosensitizers for Fluorescence Image‐Guided Photodynamic Therapy of Solid Tumors

Advanced Healthcare Materials, EarlyView.
Highly efficient heavy‐atom‐free NIR photosensitizers based on a heptamethine cyanine platform were developed for image‐guided photodynamic therapy. Both in vitro and in vivo results revealed that the R820‐3 photosensitizer with a highly twisted molecular structure exhibited potential for NIR fluorescence image‐guided photodynamic cancer therapy ...
Van‐Nghia Nguyen, Huixian Liang, Hyunsun Jeong, Jieun Bang, Chang Woo Koh, Kunemadihali Mathada Kotraiah Swamy, Sungnam Park, JaeHong Park, Fabiao Yu, Juyoung Yoon   +9 more
wiley   +1 more source

The timeliness of health plan drug coverage policy changes to FDA label revisions. [PDF]

Health Aff Sch
Enright DE, Beinfeld MT, Brennan CH, Lin Y, Motyka JD, Campbell JD, Chambers JD.   +6 more
europepmc   +1 more source

From the FDA: New labeling and use changes for Rezulin [PDF]

, 1999

openalex   +1 more source